ATE508740T1 - Mittel zur verringerung von müdigkeit - Google Patents

Mittel zur verringerung von müdigkeit

Info

Publication number: ATE508740T1
Authority: AT; Austria
Prior art keywords: fatigue; agents; reducing fatigue; salt; reducing agent
Prior art date: 2006-06-07

Application number

AT07744852T

Other languages

German (de)

English (en)

Inventor

Miho Komatsu

Koji Morishita

Takeshi Shibasaki

Itaru Toda

Original Assignee

Kyowa Hakko Bio Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-07

Filing date

2007-06-07

Publication date

2011-05-15

2007-06-07 Application filed by Kyowa Hakko Bio Co Ltd filed Critical Kyowa Hakko Bio Co Ltd

2011-05-15 Application granted granted Critical

2011-05-15 Publication of ATE508740T1 publication Critical patent/ATE508740T1/de

Links

239000003638 chemical reducing agent Substances 0.000 abstract 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
108010024636 Glutathione Proteins 0.000 abstract 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
235000013376 functional food Nutrition 0.000 abstract 1
229960003180 glutathione Drugs 0.000 abstract 1
229960003104 ornithine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Saccharide Compounds (AREA)

AT07744852T 2006-06-07 2007-06-07 Mittel zur verringerung von müdigkeit ATE508740T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2006158156		2006-06-07
PCT/JP2007/061522 WO2007142286A1 (fr)	2006-06-07	2007-06-07	Agent de réduction de la fatigue

Publications (1)

Publication Number	Publication Date
ATE508740T1 true ATE508740T1 (de)	2011-05-15

Family

ID=38801532

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07744852T ATE508740T1 (de)	2006-06-07	2007-06-07	Mittel zur verringerung von müdigkeit

Country Status (6)

Country	Link
US (1)	US20100137226A1 (fr)
EP (1)	EP2050444B1 (fr)
JP (1)	JP5085541B2 (fr)
CN (1)	CN101460159B (fr)
AT (1)	ATE508740T1 (fr)
WO (1)	WO2007142286A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101959530A (zh) *	2008-02-25	2011-01-26	味之素株式会社	糖尿病或肥胖症的预防或治疗剂
CN102552457A (zh) *	2010-12-24	2012-07-11	漆又毛	一种氨基酸和提取物组合物的药物用途
JP5997425B2 (ja) *	2011-08-18	2016-09-28	協和発酵バイオ株式会社	オルニチン含有組成物
CN102526750A (zh) *	2012-01-06	2012-07-04	安徽黄山胶囊股份有限公司	一种植物结肠溶空心胶囊
AU2013320871A1 (en) *	2012-09-28	2015-04-09	Kyowa Hakko Bio Co., Ltd.	Agent for enhancing immunity containing glutathione
JP2014159381A (ja) *	2013-02-19	2014-09-04	Kyowa Hakko Bio Co Ltd	オルニチン含有体組成改善用組成物
JP6646369B2 (ja) *	2015-06-25	2020-02-14	株式会社東洋新薬	抗疲労剤
WO2017004396A1 (fr) *	2015-06-30	2017-01-05	Nucorplabs, Inc.	Composition à mâcher pour fournir du gsh
EP3636257B1 (fr) *	2017-06-07	2024-01-03	Kao Corporation	Promoteur de métabolisme d'ammoniac
JP6829487B2 (ja) *	2019-07-11	2021-02-10	株式会社東洋新薬	抗疲労剤
JP2021020881A (ja) *	2019-07-30	2021-02-18	三菱商事ライフサイエンス株式会社	疲労回復剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1110392A (en) *	1964-09-28	1968-04-18	Yamanouchi Pharma Co Ltd	Composition containing glutathione and an amino acid or amino acids, and salts thereof
US3428025A (en) *	1966-12-27	1969-02-18	Xerox Corp	Xerographic development apparatus
ZA716628B (en) *	1970-10-15	1972-06-28	Richardson Merrell Spa	Composition and method for treatment of hepatic disease and mental fatigue
JPS5324096A (en)	1976-08-19	1978-03-06	Kyowa Hakko Kogyo Co Ltd	Preparation of l-ornithine by fermentation
JPS6174595A (ja)	1984-09-21	1986-04-16	Kyowa Hakko Kogyo Co Ltd	物質の製造方法
JPS61119194A (ja)	1984-11-15	1986-06-06	Kyowa Hakko Kogyo Co Ltd	発酵法によるｌ−オルニチンの製造法
WO1994010858A1 (fr) *	1992-11-10	1994-05-26	Otsuka Pharmaceutical Co., Ltd.	Compostion d'aliment
JPH08275752A (ja) *	1995-04-07	1996-10-22	Riken Vitamin Co Ltd	ストレス改善食品
JP2002338473A (ja) *	2001-05-15	2002-11-27	Yaizu Suisankagaku Industry Co Ltd	抗疲労組成物
US6855727B2 (en) *	2000-12-04	2005-02-15	Yaizu Suisankagaku Industry Co., Ltd.	Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
ES2269671T3 (es) *	2001-04-25	2007-04-01	Cobalz Limited	Composiciones medicas para su uso en el tratamiento o la prevencion de una insuficiencia de vitamina b12 funcional.
DE10158498A1 (de) *	2001-11-29	2003-07-24	Becker Grubmueller Anuschka	Nahrungsergänzungspräparat
US20040001817A1 (en) *	2002-05-14	2004-01-01	Giampapa Vincent C.	Anti-aging nutritional supplement
AU2004211978A1 (en) *	2003-02-10	2004-08-26	Todd Ovokaitys	Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form
US20060159759A1 (en) *	2003-03-06	2006-07-20	Kyowa Hakko Kogyo Co., Ltd	Tablet containing water-absorbing amino acid
CN101282721B (zh) *	2005-10-04	2013-05-01	协和发酵生化株式会社	改善疲劳自觉症状用组合物

2007
- 2007-06-07 AT AT07744852T patent/ATE508740T1/de not_active IP Right Cessation
- 2007-06-07 EP EP07744852A patent/EP2050444B1/fr active Active
- 2007-06-07 WO PCT/JP2007/061522 patent/WO2007142286A1/fr not_active Ceased
- 2007-06-07 CN CN2007800210370A patent/CN101460159B/zh active Active
- 2007-06-07 US US12/303,613 patent/US20100137226A1/en not_active Abandoned
- 2007-06-07 JP JP2008520613A patent/JP5085541B2/ja active Active

Also Published As

Publication number	Publication date
WO2007142286A1 (fr)	2007-12-13
EP2050444B1 (fr)	2011-05-11
CN101460159B (zh)	2011-11-23
EP2050444A4 (fr)	2009-06-03
CN101460159A (zh)	2009-06-17
US20100137226A1 (en)	2010-06-03
JP5085541B2 (ja)	2012-11-28
JPWO2007142286A1 (ja)	2009-10-29
EP2050444A1 (fr)	2009-04-22

Similar Documents

Publication	Publication Date	Title
ATE508740T1 (de)	2011-05-15	Mittel zur verringerung von müdigkeit
WO2011061330A3 (fr)	2011-07-21	Utilisation d'agents rafraîchissants physiologiques et produits contenant de tels agents
ATE456369T1 (de)	2010-02-15	Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
UA101309C2 (ru)	2013-03-25	Антагонисты активина-actrii и их применение для повышения уровня эритроцитов
IL198411A0 (en)	2010-02-17	Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
WO2007109330A3 (fr)	2007-11-22	Composés modulant le récepteur de la sip
TW200806317A (en)	2008-02-01	Methods for reducing protein aggregation
UA94221C2 (en)	2011-04-26	Lipocalin protein
MY145721A (en)	2012-03-30	Non-irritating compositions containing zinc salts
WO2012162331A3 (fr)	2013-01-17	Compositions comprenant un bouquet efficace de parfums
BR112012027055A2 (pt)	2017-07-11	agente estabilizante para proteínas farmacêuticas.
WO2006096434A3 (fr)	2007-03-29	Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete
MX2012006628A (es)	2012-07-10	Microorganismos probioticos como agentes activos para mejorar el brillo de la piel.
MY147247A (en)	2012-11-14	Organic compounds and their uses
EA200801164A2 (ru)	2008-10-30	Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
EA201100297A1 (ru)	2011-10-31	Биотесты на белок polyq
UA95103C2 (ru)	2011-07-11	Замещенные арилсульфонамиды в качестве противовирусных средств
WO2008149802A1 (fr)	2008-12-11	Agent anti-fatigue et composition orale comprenant chacun de l'andrographolide en tant que principe actif
WO2008105088A1 (fr)	2008-09-04	Agent de traitement d'une lésion de la moelle épinière
MA32717B1 (fr)	2011-10-02	Sels de n-[6-cis- (2.6-dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-4'- (trifluoromethoxy)- [1.1'-biphenyl]-3-carboxamide
NZ705917A (en)	2018-02-23	Nootropic compositions for improving memory performance
WO2004039326A3 (fr)	2004-08-12	Propofol associe a la cysteine
BR112014012966A2 (pt)	2017-06-13	método para o controle da proliferação de pseudomonas; e uso de um agente de desinfecção
WO2008120263A3 (fr)	2008-12-18	Antagonistes des récepteurs des prokinéticines, leurs dérivés et leurs utilisations
AR064214A1 (es)	2009-03-18	Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas

Legal Events

Date	Code	Title	Description
2011-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties